Monoclonal antibody to human chronic myeloid leukemia cell line MOLM-7 specifically reacts with an antigen of apoptotic cells

Leuk Res. 2002 Jan;26(1):45-54. doi: 10.1016/s0145-2126(01)00097-2.

Abstract

Monoclonal antibody 2E12 was prepared by immunization of mice with fresh cells of chronic myeloid leukemia cell line MOLM-7. A panel of 15 leukemic cell lines (myeloid, promyelocytic, erythroid, B and T lymphoid) and numerous cultured patient's leukemia and myeloma cells were tested for reactivity with 2E12 antibody. A subset of cells in all cell lines and various number of patient's cells cultivated for 10 days or more were 2E12 positive. KG-1 and HL-60 cell lines were treated by camptothecin (CAM) (5 microg/ml, 4 h), washed and further cultivated without CAM. After 24 and 48 h in culture a considerable increase of 2E12 positivity was detected both in KG-1 and HL-60 cells, which well correlated with the increase of APO2.7 positivity and the sub-G1 peaks. The 2E12 positive cells were morphologically the same as cells in PCD, possibly apoptosis. We suggest that the 2E12 antibody detects a strong antigen on apoptotic cells which could be a part of the signaling process for ingestion by phagocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antigens, Neoplasm / immunology*
  • Antineoplastic Agents, Phytogenic / toxicity
  • Apoptosis / immunology*
  • Camptothecin / toxicity
  • DNA, Neoplasm / metabolism
  • Female
  • Flow Cytometry
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Multiple Myeloma / immunology
  • Necrosis
  • Propidium / metabolism
  • Tumor Cells, Cultured / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antineoplastic Agents, Phytogenic
  • DNA, Neoplasm
  • Propidium
  • Camptothecin